Creatine is not FDA approved, but that doesn’t mean it’s unregulated or unsafe. The FDA does not approve any dietary supplements the way it approves prescription drugs. Creatine is legally sold in the United States as a dietary supplement under a regulatory framework that places the responsibility for safety on the manufacturer, not on a pre-market review by the FDA.
Why the FDA Doesn’t “Approve” Supplements
The distinction matters because “FDA approved” has a specific legal meaning. When a pharmaceutical drug gets FDA approval, it has gone through years of clinical trials proving it works for a specific medical condition and that its benefits outweigh its risks. The FDA reviews all that data before the drug can be sold.
Dietary supplements, including creatine, fall under a completely different set of regulations established by the Dietary Supplement Health and Education Act (DSHEA) of 1994. Under this law, supplement manufacturers are responsible for evaluating the safety and labeling of their own products before selling them. The FDA does not review or approve supplements for safety or effectiveness before they hit store shelves. Instead, the FDA monitors the market afterward and can take action against products that are adulterated or mislabeled.
This applies to every supplement you can buy: vitamins, fish oil, protein powder, and creatine alike. None of them are “FDA approved.”
Creatine’s GRAS Status
While creatine isn’t FDA approved as a drug, creatine monohydrate has been submitted for “Generally Recognized as Safe” (GRAS) status. GRAS is a designation the FDA uses for food ingredients that are widely accepted as safe based on scientific evidence or a long history of use. Creatine monohydrate was the subject of GRAS Notice No. 931, which was reviewed by the FDA. This is a step above simply being sold as a supplement. It signals that the available evidence supports the ingredient’s safety for its intended use.
What the Safety Evidence Shows
The most common concern people have about creatine is whether it damages the kidneys or liver. A systematic review and meta-analysis published in BMC Nephrology found that creatine supplementation causes a small, transient increase in serum creatinine, a blood marker often used to assess kidney health. But this bump is a predictable byproduct of creatine metabolism, not a sign of kidney damage. The key finding: no significant changes were observed in glomerular filtration rate (the gold standard measure of how well your kidneys are actually filtering blood), suggesting kidney function stays intact.
Several studies included in that analysis tracked participants for extended periods. One study followed creatine users for over two and a half years and found no long-term serious effects on kidney or liver function. Other studies lasting six to eight weeks at varying doses reached the same conclusion.
A large-scale analysis published in the Journal of the International Society of Sports Nutrition examined data from 685 studies involving nearly 13,000 creatine users and compared them to over 13,400 people taking placebos across 652 studies. Side effects were reported in 13.7% of creatine studies and 13.2% of placebo studies, a difference that was not statistically significant. When researchers looked at the total frequency of side effects among individual participants, the numbers were nearly identical: 4.60% for creatine users versus 4.21% for placebo groups.
Gastrointestinal issues and muscle cramping showed up slightly more often in creatine groups at the study level, but when the researchers accounted for the actual number of people affected, those differences disappeared statistically. Across 49 different side effects evaluated, there was no significant overall difference between creatine and placebo.
Adverse Event Reports Are Rare
The FDA maintains a database where consumers and healthcare providers can report problems with supplements. An analysis of 28.4 million adverse event reports found that creatine was mentioned in just 0.00072% of them. Even among those rare reports, 46.3% involved products that didn’t actually contain creatine when the ingredients were checked. And 63% of the reports that did involve creatine included other supplements or drugs alongside it, making it impossible to pin the adverse event on creatine alone. Only 37% of verified creatine-containing reports involved creatine monohydrate as the sole product.
What “Not FDA Approved” Means for You
Because supplements aren’t pre-approved, quality varies between brands. The FDA requires every creatine product to carry specific labeling: a statement of identity, net quantity, a Supplement Facts panel, a full ingredient list, and the manufacturer’s name and address. Manufacturers can make structure/function claims (like “supports muscle recovery”) but cannot claim creatine treats or cures any disease. Any structure/function claim must include a disclaimer stating the FDA has not evaluated the claim.
The bigger practical concern is purity. Without mandatory pre-market testing, some products may contain contaminants or inaccurate ingredient amounts. Third-party certification programs help fill this gap. NSF’s Certified for Sport program, for example, tests supplements for over 290 banned substances identified by the World Anti-Doping Agency, including stimulants, steroids, narcotics, diuretics, and masking agents. They also test for potentially harmful contaminants. If you want extra assurance about what’s in your creatine, look for a product carrying NSF Certified for Sport, Informed Sport, or USP verification seals.
Creatine in Pharmaceutical Research
Interestingly, creatine has been studied as a pharmaceutical intervention. A completed Phase 4 clinical trial registered with the FDA investigated creatine at 10 grams daily as an add-on treatment for adolescent females with treatment-resistant major depressive disorder. That trial classified creatine as a “U.S. FDA-Regulated Drug Product” for the purposes of the study, which is a different regulatory pathway than its current status as a supplement. No creatine-based prescription drug has received FDA approval for any medical condition, but the fact that it’s being tested in formal drug trials reflects the compound’s expanding research profile beyond sports performance.